日本語 
Pharma
I feel that four Japanese researchers have earned the 2026 Lasker Awards showing Japan’s ongoing impact in biomedical research and pharmaceutical innovation. These awards cover medical science and drug development…
Elix, LINC Launch First AI Drug Platform with Fed Learning
Elix, Inc. and the Life Intelligence Consortium (LINC) have launched the world’s…
Verified Clinical Trials launches in Japan to curb duplicates
Verified Clinical Trials (VCT) is now operating in Japan. They teamed up…
Chugai and Gero Join Forces on Aging Disease Therapies
Chugai Pharmaceutical Co., Ltd. and Singapore-based biotechnology firm Gero PTE. LTD. Gero…
Elix and LINC Unveil AI Drug Platform Using Pharma Data
Elix Inc. and the Life Intelligence Consortium (LINC), a general incorporated association…
Actair® Promotion in Japan Transitions to CEOLIA Pharma
Stallergenes Greer, together with Shionogi & Co., Ltd. and CEOLIA Pharma Co.,…
Alpha Fusion, Curadh MTR Partner on Astatine-211 Drugs
Alpha Fusion, Inc. and Curadh MTR, Inc. They plan to create a…
PHC secures exclusive rights to MaxCyte ExPERT in Japan
The Biomedical Division of PHC Corporation, a subsidiary of PHC Holdings Corporation…
PRD Therapeutics Begins First Human Trial for PRD001
PRD Therapeutics Inc. has announced a first-in-human clinical trial for PRD001. This is…
Elix, LINC Launch First AI Drug Platform with Fed Learning
Elix, Inc. and the Life Intelligence Consortium (LINC) have launched the world’s…
Verified Clinical Trials launches in Japan to curb duplicates
Verified Clinical Trials (VCT) is now operating in Japan. They teamed up…
Chugai and Gero Join Forces on Aging Disease Therapies
Chugai Pharmaceutical Co., Ltd. and Singapore-based biotechnology firm Gero PTE. LTD. Gero…
Elix and LINC Unveil AI Drug Platform Using Pharma Data
Elix Inc. and the Life Intelligence Consortium (LINC), a general incorporated association…
Actair® Promotion in Japan Transitions to CEOLIA Pharma
Stallergenes Greer, together with Shionogi & Co., Ltd. and CEOLIA Pharma Co.,…
Alpha Fusion, Curadh MTR Partner on Astatine-211 Drugs
Alpha Fusion, Inc. and Curadh MTR, Inc. They plan to create a…
PHC secures exclusive rights to MaxCyte ExPERT in Japan
The Biomedical Division of PHC Corporation, a subsidiary of PHC Holdings Corporation…
PRD Therapeutics Begins First Human Trial for PRD001
PRD Therapeutics Inc. has announced a first-in-human clinical trial for PRD001. This is…
English